Why is Akums Drugs & Pharmaceuticals Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Low Debt Company with Strong Long Term Fundamental Strength
3
With a growth in Net Profit of 168.31%, the company declared Very Positive results in Sep 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING PROFIT TO INTEREST(Q) Highest at 7.58 times
- ROCE(HY) Highest at 17.48%
- PBDIT(Q) Highest at Rs 194.73 cr.
4
Stock is technically in a Mildly Bullish range
- Multiple factors for the stock are Mildly Bullish like Bollinger Band, DOW and OBV
5
With ROE of 10.8, it has a Fair valuation with a 3.1 Price to Book Value
- Over the past year, while the stock has generated a return of 64.98%, its profits have risen by 23.6% ; the PEG ratio of the company is 1.2
How much should you buy?
- Overall Portfolio exposure to Akums Drugs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Akums Drugs for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Akums Drugs
64.98%
1.83
35.45%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
8.77%
EBIT Growth (5y)
54.47%
EBIT to Interest (avg)
4.79
Debt to EBITDA (avg)
1.17
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.61
Tax Ratio
29.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.58%
ROCE (avg)
14.04%
ROE (avg)
10.24%
Valuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
40
Price to Book Value
3.12
EV to EBIT
18.57
EV to EBITDA
14.01
EV to Capital Employed
4.82
EV to Sales
1.94
PEG Ratio
1.23
Dividend Yield
0.43%
ROCE (Latest)
25.98%
ROE (Latest)
10.77%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
26What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 7.58 times
ROCE(HY)
Highest at 17.48%
PBDIT(Q)
Highest at Rs 194.73 cr.
PBT LESS OI(Q)
Highest at Rs 125.83 cr.
PAT(Q)
Highest at Rs 112.85 cr.
DEBTORS TURNOVER RATIO(HY)
Highest at 5.62 times
NET SALES(Q)
Highest at Rs 1,342.39 cr
EPS(Q)
Highest at Rs 7.37
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Akums Drugs
Operating Profit to Interest - Quarterly
Highest at 7.58 times and Grown
each quarter in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Operating Profit (PBDIT) - Quarterly
Highest at Rs 194.73 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 125.83 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 125.83 cr has Grown at 60.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 78.34 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 112.85 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 112.85 cr has Grown at 47.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 76.33 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 1,342.39 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 7.37
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Highest at 5.62 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio